Leadership Team

Our leadership team is composed of internationally recognized experts in immunotherapy, nanomedicine, and vaccine development, with decades of combined experience translating cutting-edge science into impactful medical innovations.

Scientific Co-Founder – Expert in Peptide Therapeutics & Nanomedicine
A senior scientific leader with a distinguished background in peptide-based therapies, immunology, nanotechnology, and cancer research. With over 300 peer-reviewed publications, numerous patents, and thousands of citations, this expert has made significant contributions to the fields of nanomedicine and targeted drug delivery. They bring more than a decade of experience in therapeutic nanoparticle development and have held leading roles at top academic medical institutions in Europe. Their work spans from foundational cancer immunology to the clinical translation of novel drug delivery systems.

Chief Scientific Advisor – Leader in Vaccine Development & Immune Intervention
An accomplished immunologist and biotech innovator with extensive experience in cancer vaccines, immune modulation, and therapeutic design. This advisor has led national and international research programs, held visiting and special professorships across Europe and North America, and held executive R&D roles in multiple biotech ventures focused on human vaccines. With over 100 scientific publications, several books, and patented technologies, their leadership has been central to advancing immune-based therapies from concept to clinic.

Together, our scientific leadership propels a mission to transform innovative science into personalized cancer treatments with real-world impact.